Cargando…

Delayed methimazole-induced agranulocytosis in a 6-year old patient with Graves’ disease

BACKGROUND: Agranulocytosis is regarded as a rare side effect of methimazole (MMI) therapy that occurs in a dose dependent manner and that usually develops within the first 3–6 months of treatment. Although delayed development beyond this timeline has been documented in adults, very few children hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Puthenpura, Vidya, Desai, Kinjal, Bauer, Andrew, Marshall, Ian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013617/
https://www.ncbi.nlm.nih.gov/pubmed/27605984
http://dx.doi.org/10.1186/s13633-016-0034-6